Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL: 2070)
Saudi Arabia
· Delayed Price · Currency is SAR 31.45
-0.20 (-0.63%)
Dec 19, 2024, 3:13 PM AST
Saudi Pharmaceutical Industries and Medical Appliances Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 33.39 | -13.71 | -165.14 | 26.45 | 124.79 | -439.74 | Upgrade
|
| Depreciation & Amortization | 69.55 | 69.13 | 84.93 | 83.66 | 82.33 | 101.87 | Upgrade
|
| Other Amortization | 9.42 | 9.42 | 3.89 | 4.44 | 5.09 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.93 | -6.38 | -0.14 | 0.45 | - | -2.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | -1.08 | 0.05 | - | - | 2.39 | 140.21 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.02 | -0.04 | -3.63 | -7.81 | -3.52 | -0.73 | Upgrade
|
| Loss (Gain) on Equity Investments | -16.02 | -20 | -20.44 | -11.41 | -38.21 | 14.26 | Upgrade
|
| Provision & Write-off of Bad Debts | 31.2 | 13.71 | 10.05 | -13.86 | 1.48 | 95.74 | Upgrade
|
| Other Operating Activities | -5.37 | 188.61 | 11.05 | -6.84 | 22.48 | 114.02 | Upgrade
|
| Change in Accounts Receivable | -213.9 | -161.74 | 172.69 | 18.02 | -51.67 | 58.28 | Upgrade
|
| Change in Inventory | -118.06 | -143.03 | -76.56 | 13.02 | -44.35 | 52.29 | Upgrade
|
| Change in Accounts Payable | 66.78 | 103.54 | -57.96 | -14.27 | -105.85 | 157.6 | Upgrade
|
| Change in Other Net Operating Assets | -21.4 | 1.68 | -44.37 | -3 | 18.38 | 64.94 | Upgrade
|
| Operating Cash Flow | -156.31 | 47.73 | -99.3 | 86.71 | 9.74 | 352.32 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 790.67% | -97.24% | - | Upgrade
|
| Capital Expenditures | -99.45 | -111.42 | -78.21 | -76.24 | -164.75 | -326.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 11.77 | 7.53 | 0.65 | 1.02 | 2.03 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -10.45 | -5.94 | - | -1 | -10.4 | -7.63 | Upgrade
|
| Investment in Securities | 0.5 | -70.5 | 525.89 | 193.74 | -5.85 | -44.47 | Upgrade
|
| Other Investing Activities | 8.75 | 8.75 | 36.3 | 23.97 | 32.38 | 21.96 | Upgrade
|
| Investing Cash Flow | -88.89 | -171.57 | 484.63 | 141.48 | -146.59 | -356.45 | Upgrade
|
| Long-Term Debt Issued | - | 43.94 | - | 14.47 | 139.55 | 201.81 | Upgrade
|
| Long-Term Debt Repaid | - | -10.16 | -220.55 | -81.35 | -4.4 | -10.49 | Upgrade
|
| Net Debt Issued (Repaid) | 464.36 | 33.79 | -220.55 | -66.87 | 135.15 | 191.31 | Upgrade
|
| Repurchase of Common Stock | -19.94 | -8 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -1.28 | -0.46 | -70.74 | -118.11 | -58.98 | -118.13 | Upgrade
|
| Other Financing Activities | -86.18 | -57.6 | -49.86 | -55.97 | 2.68 | 48.56 | Upgrade
|
| Financing Cash Flow | 356.97 | -32.28 | -341.15 | -240.95 | 78.85 | 121.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6.19 | -16.15 | -38.5 | 8.35 | 13.1 | -5.94 | Upgrade
|
| Net Cash Flow | 105.58 | -172.26 | 5.69 | -4.42 | -44.89 | 111.67 | Upgrade
|
| Free Cash Flow | -255.76 | -63.68 | -177.51 | 10.47 | -155.02 | 26.01 | Upgrade
|
| Free Cash Flow Margin | -15.71% | -3.85% | -12.48% | 0.72% | -9.97% | 1.75% | Upgrade
|
| Free Cash Flow Per Share | -2.14 | -0.53 | -1.48 | 0.09 | -1.29 | 0.22 | Upgrade
|
| Cash Interest Paid | 66.82 | 58.41 | 33.41 | 20.26 | 26.73 | 34.09 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.54 | 3.97 | - | Upgrade
|
| Levered Free Cash Flow | -168.75 | -13.25 | -121.09 | -56.73 | -182.43 | 223.96 | Upgrade
|
| Unlevered Free Cash Flow | -132.16 | 23.77 | -99.63 | -37.11 | -161.43 | 257.49 | Upgrade
|
| Change in Net Working Capital | 172.46 | -1.98 | 42.69 | 68.49 | 163.54 | -591.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.